CR8226A - Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos - Google Patents
Proceso para la preparacion de 4-amino-3-quinolincarbonitrilosInfo
- Publication number
- CR8226A CR8226A CR8226A CR8226A CR8226A CR 8226 A CR8226 A CR 8226A CR 8226 A CR8226 A CR 8226A CR 8226 A CR8226 A CR 8226A CR 8226 A CR8226 A CR 8226A
- Authority
- CR
- Costa Rica
- Prior art keywords
- quinolincarbonitrilos
- amino
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Materials Engineering (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49619103P | 2003-08-19 | 2003-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR8226A true CR8226A (es) | 2008-08-21 |
Family
ID=34215972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR8226A CR8226A (es) | 2003-08-19 | 2006-02-02 | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7297795B2 (es) |
| EP (1) | EP1660453A2 (es) |
| JP (1) | JP2007502819A (es) |
| KR (1) | KR20060066733A (es) |
| CN (1) | CN1835923A (es) |
| AR (1) | AR045277A1 (es) |
| AU (1) | AU2004267061A1 (es) |
| BR (1) | BRPI0413667A (es) |
| CA (1) | CA2535385A1 (es) |
| CO (1) | CO5670369A2 (es) |
| CR (1) | CR8226A (es) |
| EC (1) | ECSP066384A (es) |
| GT (1) | GT200400165A (es) |
| IL (1) | IL173456A0 (es) |
| MX (1) | MXPA06001590A (es) |
| MY (1) | MY140542A (es) |
| NO (1) | NO20060539L (es) |
| PA (1) | PA8609301A1 (es) |
| PE (1) | PE20050344A1 (es) |
| RU (1) | RU2345069C2 (es) |
| SA (1) | SA04250258B1 (es) |
| SG (1) | SG145744A1 (es) |
| SV (1) | SV2005001855A (es) |
| TW (1) | TW200517378A (es) |
| WO (1) | WO2005019201A2 (es) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7479561B2 (en) | 2004-08-16 | 2009-01-20 | Wyeth | 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors |
| AU2006210572B2 (en) | 2005-02-03 | 2011-08-04 | The General Hospital Corporation | Method for treating gefitinib resistant cancer |
| AU2006247520A1 (en) * | 2005-05-18 | 2006-11-23 | Wyeth | 3-cyanoquinoline inhibitors of TPL2 kinase and methods of making and using the same |
| CN101180273A (zh) * | 2005-05-25 | 2008-05-14 | 惠氏公司 | 合成6-烷基氨基喹啉衍生物的方法 |
| CN101203494A (zh) * | 2005-05-25 | 2008-06-18 | 惠氏公司 | 合成经取代3-氰基喹啉和其中间物的方法 |
| EP1883621A2 (en) * | 2005-05-25 | 2008-02-06 | Wyeth | Methods of preparing 3-cyano-quinolines and intermediates made thereby |
| AU2006266045A1 (en) | 2005-07-01 | 2007-01-11 | Wyeth | Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same |
| CN103110948A (zh) | 2005-11-04 | 2013-05-22 | 惠氏公司 | mTOR抑制剂、赫赛汀和/或HKI-272的抗肿瘤组合 |
| CA2636736A1 (en) * | 2006-02-08 | 2007-08-16 | Wyeth | Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction |
| CN101195578B (zh) * | 2006-12-08 | 2012-04-25 | 上海睿智化学研究有限公司 | 1-(卤烷氧基)-2-烷氧基-5-硝基苯类化合物的合成方法 |
| US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| CA2725598C (en) | 2008-06-17 | 2013-10-08 | Wyeth Llc | Antineoplastic combinations containing hki-272 and vinorelbine |
| WO2010017163A1 (en) | 2008-08-04 | 2010-02-11 | Wyeth | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| WO2010030835A2 (en) * | 2008-09-11 | 2010-03-18 | Wyeth Llc | Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor |
| KR20140036332A (ko) | 2009-04-06 | 2014-03-25 | 와이어쓰 엘엘씨 | 네라티닙을 이용한 유방암의 치료법 |
| MX2012000048A (es) | 2009-07-02 | 2012-01-27 | Wyeth Llc | Formulaciones de comprimidos de 3-cianoquinolina y usos de los mismos. |
| CN101792416B (zh) * | 2010-01-15 | 2011-10-05 | 南京医科大学 | 一种博舒替尼的制备工艺 |
| HUE032515T2 (en) * | 2010-06-23 | 2017-09-28 | Hanmi Science Co Ltd | New condensed pyrimidine derivatives for inhibiting tyrosine kinase activity |
| WO2013187967A1 (en) | 2012-06-15 | 2013-12-19 | Institute For Cancer Research D/B/A The Research Institute Of Fox Case Cancer Center ("Fox Chase Cancer Center") | Sensitization of cancer cells to dna damage by inhibiting kinases essential for dna damage checkpoint control |
| CN102952037A (zh) * | 2012-11-18 | 2013-03-06 | 大连九信生物化工科技有限公司 | 一种2-氰基-n-(2,4-二氯-5-甲氧苯基)乙酰胺的合成方法 |
| US9776970B2 (en) | 2014-02-20 | 2017-10-03 | Apotex Inc. | Bosutinib forms and preparation methods thereof |
| CN104876865A (zh) * | 2014-02-27 | 2015-09-02 | 南京正荣医药化学有限公司 | 一种博舒替尼的制备工艺 |
| SI3319955T1 (sl) * | 2015-07-06 | 2021-01-29 | Gilead Sciences, Inc. | 6-amino-kinolin-3-karbonitrili kot modulatorji COT |
| WO2017007689A1 (en) | 2015-07-06 | 2017-01-12 | Gilead Sciences, Inc. | Cot modulators and methods of use thereof |
| CN105085398A (zh) * | 2015-09-06 | 2015-11-25 | 合肥华方医药科技有限公司 | 一种博舒替尼异构体杂质的制备方法 |
| CN105646345A (zh) * | 2016-03-16 | 2016-06-08 | 浙江海正药业股份有限公司 | 博舒替尼的新晶型及其制备方法 |
| US10059695B2 (en) | 2016-06-30 | 2018-08-28 | Gilead Sciences, Inc. | Cot modulators and methods of use thereof |
| CA3079277A1 (en) * | 2017-10-18 | 2019-04-25 | Jiangsu Hengrui Medicine Co., Ltd. | Preparation method for tyrosine kinase inhibitor and intermediate thereof |
| CN108084085B (zh) * | 2017-12-28 | 2019-11-26 | 山东铂源药业有限公司 | 一种n-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法 |
| WO2019186429A1 (en) * | 2018-03-30 | 2019-10-03 | Sun Pharmaceutical Industries Limited | A process for the preparation of bosutinib |
| CN109180578B (zh) * | 2018-10-19 | 2020-06-26 | 山东创新药物研发有限公司 | 一种博舒替尼的制备方法 |
| CN111646939A (zh) * | 2019-03-04 | 2020-09-11 | 鲁南制药集团股份有限公司 | 一种博舒替尼的制备方法 |
| CN111646955B (zh) * | 2019-03-04 | 2024-05-24 | 鲁南制药集团股份有限公司 | 一种制备博舒替尼中间体的方法 |
| TW202235416A (zh) | 2019-06-14 | 2022-09-16 | 美商基利科學股份有限公司 | Cot 調節劑及其使用方法 |
| US11655237B2 (en) | 2020-03-30 | 2023-05-23 | Gilead Sciences, Inc. | Solid forms of a Cot inhibitor compound |
| AU2021245924B2 (en) | 2020-04-02 | 2024-02-29 | Gilead Sciences, Inc. | Process for preparing a Cot inhibitor compound |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73073C2 (uk) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
-
2004
- 2004-08-13 SG SG200806052-7A patent/SG145744A1/en unknown
- 2004-08-13 AU AU2004267061A patent/AU2004267061A1/en not_active Abandoned
- 2004-08-13 EP EP04781074A patent/EP1660453A2/en not_active Withdrawn
- 2004-08-13 CN CNA2004800236697A patent/CN1835923A/zh active Pending
- 2004-08-13 KR KR1020067003360A patent/KR20060066733A/ko not_active Application Discontinuation
- 2004-08-13 BR BRPI0413667-5A patent/BRPI0413667A/pt not_active IP Right Cessation
- 2004-08-13 MX MXPA06001590A patent/MXPA06001590A/es active IP Right Grant
- 2004-08-13 CA CA002535385A patent/CA2535385A1/en not_active Abandoned
- 2004-08-13 JP JP2006523942A patent/JP2007502819A/ja not_active Withdrawn
- 2004-08-13 WO PCT/US2004/026329 patent/WO2005019201A2/en active Application Filing
- 2004-08-13 RU RU2006108524/04A patent/RU2345069C2/ru not_active IP Right Cessation
- 2004-08-16 US US10/918,947 patent/US7297795B2/en not_active Expired - Fee Related
- 2004-08-17 PE PE2004000794A patent/PE20050344A1/es not_active Application Discontinuation
- 2004-08-17 TW TW093124649A patent/TW200517378A/zh unknown
- 2004-08-18 AR ARP040102964A patent/AR045277A1/es unknown
- 2004-08-18 MY MYPI20043356A patent/MY140542A/en unknown
- 2004-08-19 SV SV2004001855A patent/SV2005001855A/es not_active Application Discontinuation
- 2004-08-19 PA PA20048609301A patent/PA8609301A1/es unknown
- 2004-08-19 GT GT200400165A patent/GT200400165A/es unknown
- 2004-08-21 SA SA04250258A patent/SA04250258B1/ar unknown
-
2006
- 2006-01-31 IL IL173456A patent/IL173456A0/en unknown
- 2006-02-02 CR CR8226A patent/CR8226A/es not_active Application Discontinuation
- 2006-02-02 NO NO20060539A patent/NO20060539L/no not_active Application Discontinuation
- 2006-02-15 CO CO06015094A patent/CO5670369A2/es unknown
- 2006-02-17 EC EC2006006384A patent/ECSP066384A/es unknown
-
2007
- 2007-10-05 US US11/973,259 patent/US20080033175A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06001590A (es) | 2006-05-19 |
| AR045277A1 (es) | 2005-10-19 |
| CN1835923A (zh) | 2006-09-20 |
| RU2006108524A (ru) | 2007-09-27 |
| EP1660453A2 (en) | 2006-05-31 |
| US20080033175A1 (en) | 2008-02-07 |
| GT200400165A (es) | 2005-04-12 |
| SG145744A1 (en) | 2008-09-29 |
| WO2005019201A2 (en) | 2005-03-03 |
| MY140542A (en) | 2009-12-31 |
| CA2535385A1 (en) | 2005-03-03 |
| SA04250258B1 (ar) | 2009-01-07 |
| PE20050344A1 (es) | 2005-06-19 |
| ECSP066384A (es) | 2006-08-30 |
| IL173456A0 (en) | 2006-06-11 |
| NO20060539L (no) | 2006-02-13 |
| BRPI0413667A (pt) | 2006-10-24 |
| SV2005001855A (es) | 2005-11-04 |
| CO5670369A2 (es) | 2006-08-31 |
| AU2004267061A1 (en) | 2005-03-03 |
| JP2007502819A (ja) | 2007-02-15 |
| KR20060066733A (ko) | 2006-06-16 |
| RU2345069C2 (ru) | 2009-01-27 |
| TW200517378A (en) | 2005-06-01 |
| WO2005019201A3 (en) | 2005-08-04 |
| US20050043537A1 (en) | 2005-02-24 |
| US7297795B2 (en) | 2007-11-20 |
| PA8609301A1 (es) | 2005-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR8226A (es) | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos | |
| NO20070753L (no) | Fremgangsmåte for fremstilling av dihydropteridinoner | |
| DK1611108T3 (da) | Fremgangsmåde til fremstilling af telmisartan | |
| DK1546122T3 (da) | Fremgangsmåde til fremstilling af valsartan | |
| MA26407A1 (fr) | Procede de preparation de combretastatines | |
| DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
| ITMI20031994A1 (it) | Procedimento per la preparazione di fludarabina fosfato | |
| NO20044332L (no) | Forbedret fremgangsmate for fremstilling av nevirapine | |
| ITMI20030346A1 (it) | Procedimento per la produzione di mesitilene. | |
| ITMI20041920A1 (it) | Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina | |
| ITMI20030018A1 (it) | Procedimento per la preparazione di composti mono- | |
| ITMI20041941A1 (it) | Processo per la preparazione di lisofosfatidilcoline | |
| ITMI20040452A1 (it) | Processo per la preparazione di oxcarbazepina | |
| ITMI20052464A1 (it) | Procedimento per la preparazi9one di norelgestromin norelgestromina | |
| ITMI20030019A1 (it) | Procedimento per la preparazione di composti mono- | |
| CL2004001156A1 (es) | Procedimiento de preparacion de compuestos heterociclicos. | |
| ITMI20041086A1 (it) | Procedimento per la preparazione di idrocarbilalogenuri | |
| ITVR20030088A1 (it) | Procedimento per la realizzazione di fasce anti-implosione per cinescopi | |
| DK1685097T3 (da) | Fremgangsmåde til fremstilling af 4-pentafluorsulfanylbenzoylguanidiner | |
| AR028111A1 (es) | Procedimiento para la produccion de isocianatos | |
| ITMI20052419A1 (it) | Processo per la preparazione di carbotioati androstanici | |
| ES1058015Y (es) | Maquina para la fabricacion de elementos de escayola | |
| FR2835839B1 (fr) | Procede de preparation de la 7beta-hydroxy-dehydroepiandrosterone | |
| ITMI20040003A1 (it) | Processo per la preparazione di 6-fluoro-2-metil-1-indanone | |
| FI20031420A (fi) | Menetelmä uusien 7-substituoitu-9-(substituoitu amino)-6-demetyyli-6-deoksitetrasykliinien valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |